ALPI and Hepatic fibrosis: The role of IAP was demonstrated in mouse models of common bile duct ligation (CBDL) and carbon tetrachloride (CCl4) models of liver fibrosis using oral supplementation of IAP as well as IAP-KO transgenic mice [16].